{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T01:32:16Z","timestamp":1790299936346,"version":"4.1.0"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,8,28]],"date-time":"2018-08-28T00:00:00Z","timestamp":1535414400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Med Case Reports"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13256-018-1702-3","type":"journal-article","created":{"date-parts":[[2018,8,27]],"date-time":"2018-08-27T07:54:50Z","timestamp":1535356490000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Carnitine palmitoyltransferase type 2 deficiency: novel mutation in a Native South American family with whole-body muscle magnetic resonance imaging findings: two case reports"],"prefix":"10.1186","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3962-6302","authenticated-orcid":false,"given":"Daniela","family":"Avila-Smirnow","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrey","family":"Boutron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda de Los \u00c1ngeles","family":"Beyt\u00eda-Reyes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oscar","family":"Contreras-Olea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfredo","family":"Caicedo-Feijoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger","family":"Gejman-Enr\u00edquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ra\u00fal","family":"Escobar-Henr\u00edquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"F\u00f6rster-Mujica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,8,28]]},"reference":[{"issue":"4","key":"1702_CR1","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.nmd.2010.01.010","volume":"20","author":"P Lafor\u00eat","year":"2010","unstructured":"Lafor\u00eat P, Vianey-Saban C, Vissing J. 162nd ENMC International Workshop: Disorders of muscle lipid metabolism in adults 28-30 November 2008, Bussum, The Netherlands. Neuromuscul Disord. 2010;20(4):283\u20139.","journal-title":"Neuromuscul Disord"},{"issue":"4","key":"1702_CR2","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.ymgme.2006.08.004","volume":"89","author":"PJ Isackson","year":"2006","unstructured":"Isackson PJ, Bennett MJ, Vladutiu GD. Identification of 16 new disease-causing mutations in the CPT2 gene resulting in carnitine palmitoyltransferase II deficiency. Mol Genet Metab. 2006;89(4):323\u201331.","journal-title":"Mol Genet Metab"},{"issue":"3","key":"1702_CR3","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1111\/j.1399-0004.2011.01786.x","volume":"82","author":"M Fanin","year":"2012","unstructured":"Fanin M, Anichini A, Cassandrini D, et al. Allelic and phenotypic heterogeneity in 49 Italian patients with the muscle form of CPT-II deficiency. Clin Genet. 2012;82(3):232\u20139.","journal-title":"Clin Genet"},{"issue":"1","key":"1702_CR4","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1179\/016164110X12767786356390","volume":"33","author":"A Anichini","year":"2011","unstructured":"Anichini A, Fanin M, Vianey-Saban C, et al. Genotype-phenotype correlations in a large series of patients with muscle type CPT II deficiency. Neurol Res. 2011;33(1):24\u201332.","journal-title":"Neurol Res"},{"issue":"2","key":"1702_CR5","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/S0887-8994(99)00133-2","volume":"22","author":"BT Darras","year":"2000","unstructured":"Darras BT, Friedman NR. Metabolic myopathies: a clinical approach; part I. Pediatr Neurol. 2000;22(2):87\u201397.","journal-title":"Pediatr Neurol"},{"issue":"3","key":"1702_CR6","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s10545-013-9666-3","volume":"37","author":"EF Diekman","year":"2014","unstructured":"Diekman EF, van der Pol WL, Nievelstein RA, et al. Muscle MRI in patients with long-chain fatty acid oxidation disorders. J Inherit Metab Dis. 2014;37(3):405\u201313.","journal-title":"J Inherit Metab Dis"},{"issue":"1","key":"1702_CR7","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/clpt.2010.55","volume":"88","author":"JP Bonnefont","year":"2010","unstructured":"Bonnefont JP, Bastin J, Lafor\u00eat P, et al. Long-term follow-up of bezafibrate treatment in patients with the myopathic form of carnitine palmitoyltransferase 2 deficiency. Clin Pharmacol Ther. 2010;88(1):101\u20138.","journal-title":"Clin Pharmacol Ther"},{"issue":"7","key":"1702_CR8","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1212\/WNL.0000000000000118","volume":"82","author":"MC \u00d8rngreen","year":"2014","unstructured":"\u00d8rngreen MC, Madsen KL, Preisler N, et al. Bezafibrate in skeletal muscle fatty acid oxidation disorders: a randomized clinical trial. Neurology. 2014;82(7):607\u201313.","journal-title":"Neurology"},{"issue":"3","key":"1702_CR9","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1007\/s10545-015-9825-9","volume":"38","author":"PG Carlier","year":"2015","unstructured":"Carlier PG, Azzabou N, de Sousa PL, et al. Skeletal muscle quantitative nuclear magnetic resonance imaging follow-up of adult Pompe patients. J Inherit Metab Dis. 2015;38(3):565\u201372.","journal-title":"J Inherit Metab Dis"},{"issue":"9","key":"1702_CR10","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1002\/nbm.3352","volume":"28","author":"C Wary","year":"2015","unstructured":"Wary C, Azzabou N, Giraudeau C, et al. Quantitative NMRI and NMRS identify augmented disease progression after loss of ambulation in forearms of boys with Duchenne muscular dystrophy. NMR Biomed. 2015;28(9):1150\u201362.","journal-title":"NMR Biomed"},{"issue":"6","key":"1702_CR11","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/j.ando.2009.08.005","volume":"70","author":"T Amezyane","year":"2009","unstructured":"Amezyane T, El Kharras A, Abouzahir A, et al. McArdle disease revealed by exercise intolerance associated with severe rhabdomyolysis [in French]. Ann Endocrinol (Paris). 2009;70(6):480\u20134.","journal-title":"Ann Endocrinol (Paris)"},{"issue":"2\u20133","key":"1702_CR12","first-page":"95","volume":"34","author":"J D\u00edaz-Manera","year":"2015","unstructured":"D\u00edaz-Manera J, Llauger J, Gallardo E, et al. Muscle MRI in muscular dystrophies. Acta Myol. 2015;34(2\u20133):95\u2013108.","journal-title":"Acta Myol"}],"container-title":["Journal of Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-018-1702-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13256-018-1702-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-018-1702-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T16:33:46Z","timestamp":1720542826000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmedicalcasereports.biomedcentral.com\/articles\/10.1186\/s13256-018-1702-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,28]]},"references-count":12,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["1702"],"URL":"https:\/\/doi.org\/10.1186\/s13256-018-1702-3","relation":{},"ISSN":["1752-1947"],"issn-type":[{"value":"1752-1947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,28]]},"assertion":[{"value":"7 August 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"DAS is a pediatric neurologist and neuromuscular disease specialist at S\u00f3tero del R\u00edo Hospital and Pontificia Universidad Cat\u00f3lica de Chile.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors\u2019 information"}},{"value":"The work reported in this article that involved human patients was conducted with the ethical approval of the Comit\u00e9 Etico Cient\u00edfico Servicio de Salud Metropolitano Sur Oriente.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from patient 1 and from the legal guardian of patient 2 for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"249"}}